Tag: Immunization

Study: Nearly a third of older adults developed new medical conditions after COVID-19

Editor's Note In this study, published by the British Medical Journal, 32% of individuals, 65 years and older, who were infected with COVID-19 developed at least one new medical condition in the months after the initial infection, the February 11 Becker’s Hospital Review reports. This 32% was 11% higher than…

Read More

By: Tarsilla Moura
February 14, 2022
Share

Vaccination rates and new COVID-19 infections by US county

Editor's Note This study led by researchers at the University of Cincinnati, finds that areas with low vaccination rates experienced a more intense surge of new cases during the third wave of the COVID-19 pandemic, primarily driven by the Delta variant. In the analysis, COVID-19 infections per 100,000 people during…

Read More

By: Judy Mathias
February 10, 2022
Share

Healthcare professionals can help combat vaccination hesitancy

  Editor's Note A Centers for Disease Control and Prevention (CDC) national survey analysis found that a recommendation from a healthcare provider may help increase COVID-19 vaccination rates, according to a February 8 report in JAMA. The survey, analyzed in the December 17, 2021, Morbidity and Mortality Weekly Report, titled…

Read More

By: Tarsilla Moura
February 10, 2022
Share

New inhaled vaccine delivers broad protection against COVID-19, variants

Editor's Note In this study, Canadian researchers at McMaster University (Hamilton, Ontario) confirm that their newly developed inhaled form of COVID-19 vaccine provides long-lasting protection against the original strain of SARS-Cov-2 and variants of concern. The researchers compared two types of adenovirus platforms for the vaccine. The adenoviruses serve as…

Read More

By: Judy Mathias
February 10, 2022
Share

Vaccine effectiveness against COVID-19 during 9 months after second vaccination

Editor's Note This study by researchers at Umea University in Sweden finds a progressive waning in vaccine effectiveness against COVID-19 of any severity during the first 9 months after the second vaccination, with the rate of waning differing by vaccine type Analyzing the total population of Sweden, vaccine effectiveness was…

Read More

By: Judy Mathias
February 8, 2022
Share

4,900+ healthcare job cuts in January linked to vaccine refusal

Editor's Note In January, 5,757 workers lost their employment because they refused to get vaccinated against COVID-19 as ordered by a federal mandate and various local mandates covering private businesses. Out of those workers, 4,934 were healthcare providers, the February 4 Becker’s Hospital Review reports from data gathered by executive…

Read More

By: Tarsilla Moura
February 8, 2022
Share

Prevalence, durability of COVID-19 antibodies in unvaccinated

Editor's Note This study led by Marty Makary, MD, MPH, and Dorry Segev, MD, PhD, at Johns Hopkins University School of Medicine, Baltimore, finds natural immunity in unvaccinated healthy US adults up to 20 months after testing positive for COVID-19. Of 1,580 study participants, antibodies were detected in: 99% of…

Read More

By: Judy Mathias
February 7, 2022
Share

CDC: Infection, hospitalization of COVID-19 patients by vaccination status

Editor's Note This analysis by the Centers for Disease Control and Prevention (CDC) on the incidence of COVID-19 and hospitalization of COVID-19 patients by vaccination status indicates that vaccination protects against severe COVID-19. Among 422,966 COVID-19 patients in Los Angeles County from November 7, 2021, to January 8, 2022, 141,928…

Read More

By: Judy Mathias
February 3, 2022
Share

Study: Racial and ethnic disparities in vaccine uptake, hesitancy

Editor's Note This study by researchers at the Massachusetts General Hospital and Harvard Medical School, Boston, finds that racial and ethnic minorities have been more hesitant or unwilling to be vaccinated for COVID-19, compared to Whites. Of study participants in the US (87,388) and UK (1,254,294): Vaccine hesitancy was greater…

Read More

By: Judy Mathias
February 2, 2022
Share

Frequency of adverse events in placebo groups of COVID-19 vaccine trials

Editor's Note This meta-analysis, led by researchers at Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, finds that the rate of nocebo responses in placebo groups of COVID-19 vaccine trials was substantial. The researchers analyzed adverse event reports for 45,380 COVID-19 vaccine trial participants (22,578 placebo recipients and…

Read More

By: Judy Mathias
January 25, 2022
Share
Live chat by BoldChat